Public Employees Retirement System of Ohio reduced its holdings in The Clorox Company (NYSE:CLX - Free Report) by 52.7% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 38,261 shares of the company's stock after selling 42,624 shares during the quarter. Public Employees Retirement System of Ohio's holdings in Clorox were worth $4,594,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Revisor Wealth Management LLC grew its stake in Clorox by 7.1% in the second quarter. Revisor Wealth Management LLC now owns 2,881 shares of the company's stock valued at $370,000 after acquiring an additional 192 shares during the period. KFG Wealth Management LLC grew its stake in Clorox by 9.5% in the second quarter. KFG Wealth Management LLC now owns 5,121 shares of the company's stock valued at $615,000 after acquiring an additional 443 shares during the period. GAMMA Investing LLC grew its stake in Clorox by 12.3% in the second quarter. GAMMA Investing LLC now owns 2,663 shares of the company's stock valued at $320,000 after acquiring an additional 292 shares during the period. ABLE Financial Group LLC grew its stake in Clorox by 20.8% in the second quarter. ABLE Financial Group LLC now owns 4,680 shares of the company's stock valued at $562,000 after acquiring an additional 805 shares during the period. Finally, Farmers & Merchants Investments Inc. grew its stake in Clorox by 285.4% in the second quarter. Farmers & Merchants Investments Inc. now owns 22,489 shares of the company's stock valued at $2,700,000 after acquiring an additional 16,654 shares during the period. Institutional investors and hedge funds own 78.53% of the company's stock.
Insider Activity
In related news, COO Eric H. Reynolds sold 15,041 shares of the business's stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.57% of the company's stock.
Clorox Stock Performance
NYSE:CLX opened at $122.95 on Tuesday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37. The firm has a market cap of $15.04 billion, a price-to-earnings ratio of 18.86, a PEG ratio of 1.00 and a beta of 0.52. The business's fifty day moving average is $123.46 and its 200 day moving average is $130.06.
Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. During the same period in the previous year, the company posted $1.82 EPS. The firm's revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Research analysts predict that The Clorox Company will post 7.15 EPS for the current year.
Clorox Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. The ex-dividend date is Wednesday, October 22nd. Clorox's payout ratio is presently 76.07%.
Analysts Set New Price Targets
A number of equities research analysts have commented on CLX shares. UBS Group reduced their price objective on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research note on Thursday, July 17th. Citigroup reaffirmed a "neutral" rating and set a $135.00 target price (down previously from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. Jefferies Financial Group cut their target price on Clorox from $167.00 to $145.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. Wells Fargo & Company cut their target price on Clorox from $130.00 to $125.00 and set an "equal weight" rating on the stock in a research report on Thursday, September 25th. Finally, JPMorgan Chase & Co. lifted their target price on Clorox from $133.00 to $135.00 and gave the company a "neutral" rating in a research report on Monday, September 8th. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Reduce" and an average target price of $141.73.
Read Our Latest Research Report on CLX
Clorox Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.